US FDA Approved Zydus Lifesciences’ Generic Drug to Treat Myxedema Coma

As per a financial exchange documenting, Zydus Lifesciences Restricted, previously Cadila Medical services Restricted, has gotten endorsement from the US wellbeing controller to showcase a conventional item. In a BSE statement, the company said that Zydus has received final approval from the United States Food and Drug Administration (USFDA) for levothyroxine sodium for injection, 100 […]

Continue Reading